Hangzhou Tigermed Consulting Co., Lt announced that at the first meeting of the fifth session of the Board held on May 23, 2023 the Board has considered and approved the appointment of Dr. Ye Xiaoping as the chairman of the fifth session of the Board and his term shall commence on the date of approval of the Board Meeting until the conclusion of the fifth session of the Board and Supervisory Committee considered and approved the appointment of Mr. Zhang Binghui as the chairman of the fifth session of the Supervisory Committee and his term shall commence on the date of approval of the Supervisory Committee Meeting until the conclusion of the fifth session of the Supervisory Committee. The Board has considered and approved appointment, Ms. Yang Chengcheng as the chief financial officer of the Company, Ms. Li Xiaori as the secretary to the Board and Ms. Ruan Xinhui as the representative of securities affairs of the Company. The term of their appointments shall commence on the date of approval of the Board Meeting until the conclusion of the fifth session of the Board.

The composition of the Board committees of the fifth session of the Board are as follows: the audit committee of the Board will comprise Mr. Liu Kai Yu Kenneth, Dr. Yang Bo and Mr. Yuan Huagang, and will be chaired by Mr. Liu Kai Yu Kenneth; the nomination committee of the Board will comprise Dr. Yang Bo, Mr. Wen Zengyu and Mr. Liu Kai Yu Kenneth, and will be chaired by Dr. Yang Bo; the remuneration and evaluation committee of the Board will comprise Mr. Yuan Huagang Mr. Liu Kai Yu Kenneth and Ms. Cao Xiaochun, and will be chaired by Mr. Yuan Huagang; and the strategic development committee of the Board will comprise Dr. Ye Xiaoping, Mr. Wu Hao, Dr. Yang Bo and Mr. Yuan Huagang, and will be chaired by Dr. Ye Xiaoping.